FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037688001> ?p ?o ?g. }

• W3037688001 abstract "Abstract Background The clinical onset of borderline personality disorder (BPD) usually occurs in young people (aged 12–25 years) and commonly leads to difficulty achieving and maintaining vocational (education and/or employment) engagement. While current psychosocial interventions lead to improvements in psychopathology, they have little effect upon functioning. Individual Placement and Support (IPS) is a client-driven model that assists individuals with severe mental illness to engage with education and/or employment appropriate to their personal goals, and that provides ongoing support to maintain this engagement. The objective of the INdividual Vocational and Educational Support Trial (INVEST) is to evaluate the effectiveness of adding IPS to an evidence-based early intervention programme for BPD, with the aim of improving vocational outcomes. Methods/design INVEST is a single-blind, parallel-groups, randomised controlled trial (RCT). The randomisation is stratified by gender and age and uses random permuted blocks. The interventions are 39 weeks of either IPS, or ‘usual vocational services’ (UVS). Participants will comprise 108 help-seeking young people (aged 15–25 years) with three or more DSM-5 BPD features and a desire to study or work, recruited from the Helping Young People Early (HYPE) early intervention programme for BPD at Orygen, in Melbourne, Australia. All participants will receive the HYPE intervention. After baseline assessment, staff who are blind to the intervention group allocation will conduct assessments at 13, 26, 39 and 52 weeks. At the 52-week primary endpoint, the primary outcome is the number of days in mainstream education/employment since baseline. Secondary outcomes include the cost-effectiveness of the intervention, quality of life, and BPD severity. Discussion Current treatments for BPD have little impact on vocational outcomes and enduring functional impairment is prevalent among this patient group. IPS is a targeted functional intervention, which has proven effective in improving vocational outcomes for adults and young people with psychotic disorders. This trial will investigate whether IPS is effective for improving vocational (employment and educational) outcomes among young people with subthreshold or full-syndrome BPD. Trial registration Australian New Zealand Clinical Trials Registry, ID: ACTRN12619001220156 . 13 September 2019." @default.
• W3037688001 created "2020-07-02" @default.
• W3037688001 creator A5002996800 @default.
• W3037688001 creator A5006657549 @default.
• W3037688001 creator A5008664493 @default.
• W3037688001 creator A5029804947 @default.
• W3037688001 creator A5031580333 @default.
• W3037688001 creator A5032261530 @default.
• W3037688001 creator A5041766728 @default.
• W3037688001 creator A5046631778 @default.
• W3037688001 creator A5055206375 @default.
• W3037688001 creator A5062441538 @default.
• W3037688001 creator A5068152389 @default.
• W3037688001 creator A5069857458 @default.
• W3037688001 creator A5072544830 @default.
• W3037688001 creator A5073386642 @default.
• W3037688001 creator A5080808073 @default.
• W3037688001 date "2020-06-26" @default.
• W3037688001 modified "2023-09-25" @default.
• W3037688001 title "INdividual Vocational and Educational Support Trial (INVEST) for young people with borderline personality disorder: study protocol for a randomised controlled trial" @default.
• W3037688001 cites W109483678 @default.
• W3037688001 cites W1557388022 @default.
• W3037688001 cites W1568692278 @default.
• W3037688001 cites W1811633118 @default.
• W3037688001 cites W1945087782 @default.
• W3037688001 cites W1974626200 @default.
• W3037688001 cites W1981848336 @default.
• W3037688001 cites W1983997158 @default.
• W3037688001 cites W1987209737 @default.
• W3037688001 cites W1998043299 @default.
• W3037688001 cites W1998595124 @default.
• W3037688001 cites W2011624065 @default.
• W3037688001 cites W2045930540 @default.
• W3037688001 cites W2058949942 @default.
• W3037688001 cites W2066614172 @default.
• W3037688001 cites W2074551592 @default.
• W3037688001 cites W2079825557 @default.
• W3037688001 cites W2081747883 @default.
• W3037688001 cites W2084779737 @default.
• W3037688001 cites W2093242322 @default.
• W3037688001 cites W2094569577 @default.
• W3037688001 cites W2107582521 @default.
• W3037688001 cites W2119355289 @default.
• W3037688001 cites W2120702185 @default.
• W3037688001 cites W2122775094 @default.
• W3037688001 cites W2130880572 @default.
• W3037688001 cites W2136456709 @default.
• W3037688001 cites W2139568741 @default.
• W3037688001 cites W2148730259 @default.
• W3037688001 cites W2157132549 @default.
• W3037688001 cites W2164835319 @default.
• W3037688001 cites W2168062411 @default.
• W3037688001 cites W2171287344 @default.
• W3037688001 cites W2171811563 @default.
• W3037688001 cites W2181018179 @default.
• W3037688001 cites W2211490350 @default.
• W3037688001 cites W2338814622 @default.
• W3037688001 cites W2395810429 @default.
• W3037688001 cites W2475065550 @default.
• W3037688001 cites W2480799424 @default.
• W3037688001 cites W2502476383 @default.
• W3037688001 cites W2532288759 @default.
• W3037688001 cites W2592963919 @default.
• W3037688001 cites W2594611275 @default.
• W3037688001 cites W2598006560 @default.
• W3037688001 cites W2613339928 @default.
• W3037688001 cites W2757770936 @default.
• W3037688001 cites W2768404558 @default.
• W3037688001 cites W2784244485 @default.
• W3037688001 cites W2788440313 @default.
• W3037688001 cites W2793660338 @default.
• W3037688001 cites W2808241197 @default.
• W3037688001 cites W2808440574 @default.
• W3037688001 cites W2810997564 @default.
• W3037688001 cites W2884268661 @default.
• W3037688001 cites W2893792582 @default.
• W3037688001 cites W2902114326 @default.
• W3037688001 cites W2949899028 @default.
• W3037688001 cites W2987143591 @default.
• W3037688001 cites W3124593434 @default.
• W3037688001 cites W4211250673 @default.
• W3037688001 cites W4243320567 @default.
• W3037688001 cites W4246855025 @default.
• W3037688001 cites W4247665917 @default.
• W3037688001 cites W4248886280 @default.
• W3037688001 cites W4255575156 @default.
• W3037688001 cites W4295805873 @default.
• W3037688001 doi "https://doi.org/10.1186/s13063-020-04471-3" @default.
• W3037688001 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7320570" @default.
• W3037688001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32591007" @default.
• W3037688001 hasPublicationYear "2020" @default.
• W3037688001 type Work @default.
• W3037688001 sameAs 3037688001 @default.
• W3037688001 citedByCount "8" @default.
• W3037688001 countsByYear W30376880012021 @default.
• W3037688001 countsByYear W30376880012022 @default.
• W3037688001 countsByYear W30376880012023 @default.
• W3037688001 crossrefType "journal-article" @default.
• W3037688001 hasAuthorship W3037688001A5002996800 @default.
• W3037688001 hasAuthorship W3037688001A5006657549 @default.

• next